Review paper:
Kim PS; Djazayeri S; Zeineldin R. Novel nanotechnology
approaches to diagnosis and therapy of ovarian cancer.
Gynecologic Oncology.
2011, 120:393-403.
Dr. Paul Kim
PharmD
Class of 2012
Dr. Shabdis Djazayeri
PharmD
Class of 2012
Amal Abdulghani
Graduate Student
Musaed Alkholief
Graduate Student
Poster:
First Annual NanoWorcester
Poster:
AlKholief M, Abdulghani A, Zeineldin R. Intracellular
fate of carbon nanotubes targeting specific receptors
on ovarian cancer cells. Nano in Cancer – American
Association of Cancer Research (AACR) special
conference. Jan 12-15,
2011. Miami, Fl.
Poster:
First Annual NanoWorcester
Symposium, MCPHS, Feb
2011
Review paper:
Cowden Dahl K, Chan TW, Balkhi B, Zeineldin R. focus on
Trabectedin. Clinical Medicine Reviews in Oncology.
2011,
3:93-105.
Teresa
Bander
Dr. Joseph Youkhanna
PharmD
Class of 2011
Dr. Joan Syoufjy
PharmD
Class of 2011
Reema Zeineldin, Ph.D.
My students' publications / presentations
Poster:
Amal Abdulghani, Nhu Nguyen, Abdullah Assiri, Sarah
Liu, Reema Zeineldin. A novel ozone-sensitive
nanotechnology platform for treatment of ovarian
cancer. Gordon Conference on Cancer
Nanotechnology. Colby College, Waterville, ME. July
17-21,
2011.
Amal Abdulghani
Graduate Student
Dr. Nhu Nguyen
PharmD
Class of 2013
Dr. Abdullah Assiri
PharmD
Class of 2013
Poster:
Jessica Rogers, Dennis Benko, Ahmed Ashour, Reema
Zeineldin. Inhibition of Rac1 and CDC42 disrupts formation of
spheroids in ovarian cancers. 2011 ASHP Midyear Clinical
Meeting. New Orleans, Louisiana, December 4-8,
2011.
Dr. Dennis Benko
PharmD
Class of 2012
Dr. Jessica Rogers
PharmD
Class of 2012
Poster:
Kirill Goncharov, Reema Zeineldin. Sensitizing resistant ovarian
cancer cells to chemotherapy through inhibition of small
GTPases. The American Association for Cancer Research.
Chicago, IL. April 1-4,
2012.
Dr. Kirill Goncharov
PharmD
Class of 2012
Poster:
Amal Abdulghani*, Reema Zeineldin. Employing the
inflammatory environment for drug release from
supported lipid bilayers in ovarian cancer. Second
Annual NanoWorcester Symposium. Worcester
Polytechnic Institute, Worcester, MA. March 17,
2012.
Review paper:
Youkhanna J, Syoufjy J, Rhorer M, Oledeinde O, Zeineldin R.
Towards nanotechnology-based solutions for a particular
disease. Invited review to Nanotechnology Reviews.
2013.
Dr. Oyebola Oledeinde
& Dr. Marry Rhorer,
PharmD
Class of 2013
Amal Abdulghani tied for 1st Place Prize for her poster in the Third Annual
NanoWorcester Symposium held at Clark University on September 28, 2013. Her
poster title: Employing the Inflammatory Environment for Drug Release from Lipid
Particles in Ovarian Cancer. Amal Abdulghani, Reema Zeineldin.
Amal Abdulghani
(MS in Pharmaceutics 2014)
Amal Abdulghani
(MS in Pharmaceutics 2014)
2nd Annual School of Pharmacy-Worcester/Manchester Research Day, MCPHS, Worcester, MA. April 11, 2013:
  • Oyebola Oladeinde, Mary Rhorer, Reema Zeineldin. Viability of adherent and multicellular aggregates (MCAs) of
    ovarian cancer cells when treated with cisplatin.
  • Irene Zaitouna, Reema Zeineldin. Distance education: Does it make a difference?
  • Lola Adebukunola Adenuga, Reema Zeineldin. Avoiding inappropriate tablet splitting.
  • Ramin Amini, Josephine Dinh, Reema Zeineldin. The effects of counseling on patients’ adherence to medication.
  • Mohamed Sayed, Hui En Huang, Reema Zeineldin. The Role of Rac1 in ovarian cancer.
  • Amy Beshai, Christian Bialk, Reema Zeineldin. Making of a pharmacy dean: The leader of tomorrow.
  • Aleksandra Ferdman, Reema Zeineldin. Role of the pharmacist in the time of drug shortages: Compounding as a
    coping strategy.
  • Jay Xu, Reema Zeineldin. Does crushing of time-release pantoprazole affect its bioavailability?
  • Hui En Huang, John Sekab, Raissa Noubissie, Thu Vo, Reema Zeineldin.  Evaluating cytotoxicity of Rac1 inhibitor on
    ovarian cancer cells.
  • Meg Crighton, Toan La, Allen Yu, Reema Zeineldin. Detecting generation of reactive oxygen species by activated
    macrophages.
2nd Annual School of Pharmacy-Worcester/Manchester Research Day,
MCPHS University, Worcester, MA. April 11, 2013:
1st Annual School of Pharmacy-Worcester/Manchester Research Day,
MCPHS University, Worcester, MA. April 6, 2012:
  • Annmae C. Javier, Reema Zeineldin. The impact of service learning
    projects of healthcare professionals on the adolescent population.
  • Cherice Petit Cuthbert, Reema Zeineldin. Career assessments:
    matching PharmD students to careers..
  • Ali Chehab, Mohamed Sayed, Reema Zeineldin. Effects of small Rho-
    GTPase inhibitors on ovarian cancer migration and aggregation.
  • Nirmit Patel*, Reema Zeineldin. Stability of clopidogrel (PLAVIX®) is an
    extemporaneously compounded oral suspension.
  • Darbi Downey, Reema Zeineldin. How well are sterility guidelines
    adhered to and enforced in pharmacy compounding?
  • Priyanka Khanna, Reema Zeineldin. Expert’s perceptions of the
    pharmacist’s role in veterinary medicine.
3rd Annual School of Pharmacy-Worcester/Manchester Research Day,
MCPHS University, Worcester, MA. April 10, 2014:
  • Mini Abraham,Thamer Alqurashi, Patricia Follet, Ashley Lee, Sarah
    Mian, Daisy Powers, Giuseppe Troia, Reema Zeineldin. Determining
    the effect of Rac‐1 inhibition on the expression of Claudin‐4 in
    ovarian cancer.
  • Hui En Huang, Reema Zeineldin. Rac1 inhibitor may improve ovarian
    cancer sensitivity to cisplatin.
  • Meg Crighton, Rich Albano, Allen Yu, Reema Zeineldin. Evaluation of
    cell proliferation of ovarian cancer cells after inhibiting Rac1.
Amal Abdulghani, Reema Zeineldin. Employing the inflammatory
environment for drug release from lipid carriers. Annual Meeting for the
American Association of Pharmaceutical Scientists-North East Regional
Discussion Group (AAPS-NERDG). Rocky Hill, CT. April 19, 2013.
Mohamed Sayed, Hui En Huang, Mary Rhorer, Oyebola Oladeinde,
Reema Zeineldin. Role of Rac1 in ovarian cancer. Annual Meeting
for the American Association of Pharmaceutical Scientists-North
East Regional Discussion Group (AAPS-NERDG). Rocky Hill, CT.
April 19, 2013.
Amal Abdulghani, Reema Zeineldin. Developing a biosensor for reactive oxygen species. Gordon
Conference on Bioanalytical Sensors. Salve Regina University, Newport, RI. June 22-27, 2014.

Hui En Huang, Reema Zeineldin. Rac1 inhibitor improves ovarian cancer sensitivity to cisplatin.
Submitted to 2013 American Society of Health-Systems Pharmacists (ASHP) Midyear Clinical
Meeting. Orlando, FL. December 8-12, 2013.

Amal Abdulghani, Reema Zeineldin. Releasing content of lipid drug delivery vehicles by
immune-related molecules. Second Cancer Nanotechnology Gordon Research Conference.
Mount Snow Resort, West Dover, VT. July 14-19, 2013.
Hui En
Amal